Clinical Trial Update: Standard Versus Continuous Capecitabine in Advanced Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 2/3 trial comparing standard versus continuous capecitabine in metastatic breast cancer, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Hospital San Carlos, Madrid | Conditions: Metastatic Breast Cancer | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-12-18